Exact Mass: 333.98631759999995
Exact Mass Matches: 333.98631759999995
Found 133 metabolites which its exact mass value is equals to given mass value 333.98631759999995,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Lormetazepam
Lormetazepam, also known as methyllorazepam or (+-)-lorazepam, is a member of the class of compounds known as 1,4-benzodiazepines. 1,4-benzodiazepines are organic compounds containing a benzene ring fused to a 1,4-azepine. Lormetazepam is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Lormetazepam can be found in potato, which makes lormetazepam a potential biomarker for the consumption of this food product. Lormetazepam is a non-carcinogenic (not listed by IARC) potentially toxic compound. Lormetazepam is a drug which is used for the treatment of short-term insomnia [l927. The Dutch, British, and French system called the System of Objectified Judgement Analysis for assessing whether drugs should be included in drug formularies based on clinical efficacy, adverse effects, pharmacokinetic properties, toxicity, and drug interactions was used to assess lormetazepam. A Dutch analysis using the system found that lormetazepam could be suitable to be included in drug prescribing formularies, although zolpidem, zopiclone, and temazepam had higher scores and thus can be seen as relatively favorable . The primary manifestation of overdosage ranges from drowsiness to coma and symptoms may include ataxia, hypotension, hypotonia, respiratory depression which may lead to death [L927]. Lormetazepam (INN, or methyl-lorazepam, is a drug which is a short to intermediate acting 3-hydroxy benzodiazepine derivative. It possesses hypnotic, anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Lormetazepam is considered a hypnotic benzodiazepine and is officially indicated for moderate to severe insomnia. Lormetazepam is a short-acting benzodiazepine and is sometimes used in patients who have difficulty in maintaining sleep or falling asleep. Hypnotics should only be used on a short-term basis or, in those with chronic insomnia, on an occasional basis. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
3,3',4',5,6,7,8-Heptahydroxyflavone
3,3,4,5,6,7,8-Heptahydroxyflavone is isolated from petals of African marigold (Tagetes erecta
2-Methyl-1,4-naphthalenediol bis(dihydrogen phosphate)
Prothrombogenic vitamin. Prothrombogenic vitamin
Menadiol disulfate
Menadiol disulfate is a synthetic vitamin K analogue; prothrombogenic agent. Synthetic vitamin K analogue; prothrombogenic agent
5-(3',4',5'-Trihydroxyphenyl)-gamma-valerolactone-O-methyl-O-sulphate
C12H14O9S (334.03585140000007)
5-(3,4,5-Trihydroxyphenyl)-gamma-valerolactone-O-methyl-O-sulphate belongs to the family of Methoxyphenols and Derivatives. These are compounds containing a methoxy group attached to the benzene ring of a phenol moiety.
6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide
C12H6N4O6S (334.00080560000004)
(5R,6S)-3-(2-Carbamoyloxyethylsulfanyl)-6-(1-hydroxyethyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
Chlorsulfaquinoxaline
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
afrostyraxthioside C|methylsulfonylthiomethyl 1-thio-beta-D-glucopyranoside
6-chloro-4,5,7-trihydroxy-9,10-dioxoanthracene-2-carboxylic acid
Lormetazepam
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Loramet
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
6-chloro-4,5,7-trihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid
4-([2,2-bithiophen]-5-yl)but-3-yne-1,2-diyl diacetate
Magnesium oratate
A - Alimentary tract and metabolism > A12 - Mineral supplements > A12C - Other mineral supplements > A12CC - Magnesium
Hexafluoro-2,3-bis-(trifluoromethyl)-2,3-butanediol
C6H2F12O2 (333.98631759999995)
3-[4-[(4-CHLOROBENZYL)OXY]PHENYL]-5-(CHLOROMETHYL)-1,2,4-OXADIAZOLE
5-bromo-1-(2-oxo-2-pyrrolidin-1-ylethyl)indole-3-carbaldehyde
ETHYL 5-AMINO-1-(2-BROMOPHENYL)-4-CYANO-1H-PYRAZOLE-3-CARBOXYLATE
C13H11BrN4O2 (334.00653259999996)
ETHYL 5-AMINO-1-(3-BROMOPHENYL)-4-CYANO-1H-PYRAZOLE-3-CARBOXYLATE
C13H11BrN4O2 (334.00653259999996)
N-(4-chlorophenyl)-1-(pyrimidin-2-yl)-1H-pyrrole-2-sulfonamide
3-(4-Bromophenyl)-5-(2-chlorophenyl)-1,2,4-oxadiazole
3-(2-Bromophenyl)-5-(4-chlorophenyl)-1,2,4-oxadiazole
(Z)-2-(2,4-DICHLORO-5-FLUORO-BENZOYL)-3-ETHOXY-ACRYLIC ACID ETHYL ESTER
Methyl 3-(trifluoromethylsulfonyloxy)-2-naphthoate
C13H9F3O5S (334.01227800000004)
N-(3-IODO-4-METHOXY-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE
C11H15IN2O2 (334.01782399999996)
tert-Butyl (5-Bromo-2-(methylthio)-6-oxopyrimidin-1-yl)acetate
C11H15BrN2O3S (333.99867000000006)
3-BROMO-5-METHOXY-2,6-DINITRO-BENZOIC ACID METHYL ESTER
4,5-dichloro-2-(4-methoxyphenyl)sulfonylpyridazin-3-one
C11H8Cl2N2O4S (333.95818280000003)
Ethyl 5-fluoro-3-iodo-1H-pyrrolo[2,3-b]pyridine-2-carboxylate
C10H8FIN2O2 (333.96145499999994)
4-(bromomethyl)-1-methyl-5-phenoxy-3-(trifluoromethyl)pyrazole
ETHANONE, 1-[4-CHLORO-1-(PHENYLSULFONYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]-
3-Methylbutyl 2-hydroxy-5-iodobenzoate
C12H15IO3 (334.00659099999996)
methyl 3-iodo-4-[(2-methylpropan-2-yl)oxy]benzoate
C12H15IO3 (334.00659099999996)
ethyl 3-iodo-4-propan-2-yloxybenzoate
C12H15IO3 (334.00659099999996)
1-(4-BROMOPHENYL)-5-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID
4-(4-CHLOROPHENYL)-5-(TRIFLUOROMETHYL)THIOPHEN-2-CARBOXYLIC ACID ETHYLESTER
3-(4-Bromophenyl)-5-(4-chlorophenyl)-1,2,4-oxadiazole
Ethyl 5-amino-1-(4-bromophenyl)-4-cyano-1H-pyrazole-3-carboxylate
C13H11BrN4O2 (334.00653259999996)
3-(2-Bromophenyl)-5-(2-chlorophenyl)-1,2,4-oxadiazole
3-(2-Bromophenyl)-5-(3-chlorophenyl)-1,2,4-oxadiazole
Propanamide, N-(4-iodo-2-methoxy-3-pyridinyl)-2,2-dimethyl-
C11H15IN2O2 (334.01782399999996)
METHYL 2-TRIFLUOROMETHANESULFONYLOXY-1-NAPHTHOATE
C13H9F3O5S (334.01227800000004)
DICHLORO(2,6,10-DODECATRIENE-1,12-DIYL)RUTHENIUM(IV)
3-Iodo-4-(3-methylbutoxy)benzoic acid
C12H15IO3 (334.00659099999996)
3-iodo-4-pentan-2-yloxybenzoic acid
C12H15IO3 (334.00659099999996)
4-(2,2-Dimethylpropoxy)-3-iodobenzoic acid
C12H15IO3 (334.00659099999996)
1-(4-Bromophenyl)-3-(2-phenylethyl)thiourea
C15H15BrN2S (334.01392500000003)
1-benzyl-2-(methylsulfanyl)-4,5-dihydro-1H-imidazole hydroiodide
6-Chloro-4,5,7-trihydroxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid
5-(4-chloro-2-hydroxy-phenoxy)-N-(5-methylisoxazol-3-yl)furan-2-carboxamide
(2R,3R,4S,5R,6S)-2,3,4,5,6-pentahydroxy-7-oxo-8-phosphonooxyoctanoic acid
C8H15O12P (334.03011200000003)
2-hydroxy-2-[(2R,3S,4R,5S,6R)-3,4,5,6-tetrahydroxy-6-(phosphonooxymethyl)oxan-2-yl]acetic acid
C8H15O12P (334.03011200000003)
4-Chloro-6-[5-(4-Methoxyphenyl)-1,2,3-Thiadiazol-4-Yl]benzene-1,3-Diol
5-[(2-chlorophenoxy)methyl]-N-(2-thiazolyl)-2-furancarboxamide
2-(2-bromo-4-methylphenoxy)-N-(pyridin-2-ylmethyl)acetamide
2-[2-(4-Fluoroanilino)-4-thiophen-2-yl-5-thiazolyl]acetic acid
4-Amino-2-[(2,5-dichlorophenyl)-oxomethyl]isoindole-1,3-dione
3-[3-(2-bromophenyl)acryloyl]-4-hydroxy-6-methyl-2H-pyran-2-one
Sodium molybdate heptahydrate
H14MoNa2O11 (333.93855440000004)
A hydrate that is the heptahydrate form of sodium molybdate.
6-bromo-2-[(3-methoxyphenoxy)methyl]-1H-imidazo[4,5-b]pyridin-4-ium
C14H13BrN3O2+ (334.01910780000003)
[3-(7-Hydroxy-4-oxochromen-2-yl)phenyl] hydrogen sulate
[3-(3-Hydroxy-4-oxochromen-2-yl)phenyl] hydrogen sulate
[1-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-3-oxopropyl] hydrogen sulate
C12H14O9S (334.03585140000007)
9-Iodo-8-methyl-3-oxo-2-oxabicyclo(4.4.0)dec-4-ene-6,8-carbolactone
C11H11IO4 (333.97020760000004)
5-(3,4,5-Trihydroxyphenyl)-gamma-valerolactone-O-methyl-O-sulphate
C12H14O9S (334.03585140000007)
H4R antagonist 1
C11H11BrN8 (334.02899859999997)
H4R antagonist 1 is a potent and highly selective histamine H4 receptor (H4R) antagonist with an IC50 of 27 nM. H4R antagonist 1 does not show any noticeable binding affinity to other subtypes of histamine receptors, H1R, H2R, and H3R[1].